Clinical Guidelines and Standards · Guidelines by Clinical Area

Practice Bulletin Summary No. 152: Emergency Contraception

ACOG

Published September 2015 Obstetrics and Gynecology, 126(3), 685-686
DOI 10.1097/01.AOG.0000471179.25809.d8 PMID 26287780

Abstract

Emergency contraception, also known as postcoital contraception, is therapy used to prevent pregnancy after an unprotected or inadequately protected act of sexual intercourse. Common indications for emergency contraception include contraceptive failure (eg, condom breakage or missed doses of oral contraceptives) and failure to use any form of contraception (1-3). Although oral emergency contraception was first described in the medical literature in the 1960s, the U.S. Food and Drug Administration (FDA) approved the first dedicated product for emergency contraception in 1998. Since then, several new products have been introduced. Methods of emergency contraception include oral administration of combined estrogen-progestin, progestin only, or selective progesterone receptor modulators and insertion of a copper intrauterine device (IUD). Many women are unaware of the existence of emergency contraception, misunderstand its use and safety, or do not use it when a need arises (4-6). The purpose of this Practice Bulletin is to review the evidence for the efficacy and safety of available methods of emergency contraception and to increase awareness of these methods among obstetrician-gynecologists and other gynecologic providers.

Topics

By this author

Related research

Clinical Guidelines and Standards › Guidelines by Clinical Area › Contraception Eligibility Criteria · Therapeutics › Hormonal Agents › Progesterone and Progestins · Contraception › Emergency Contraception › Mechanism and Effectiveness
PMID 26287780 26287780 DOI 10.1097/01.AOG.0000471179.25809.d8 10.1097/01.AOG.0000471179.25809.d8 ACOG et al. 2015, ACOG 2015